Support Centre
20 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

New application
Updating record

governing board
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Acupuncture for shortness of breath in cancer patients
DOI 10.1186/ISRCTN89462491
ClinicalTrials.gov identifier NCT00067691
EudraCT number
Public title Acupuncture for shortness of breath in cancer patients
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis The purpose of this study is to determine whether acupuncture is effective in relieving shortness of breath among breast and lung cancer patients
Lay summary
Ethics approval The study was approved by the institutional review board at Memorial Sloan-Kettering Cancer Center (MSKCC) in accordance with an assurance filed with and approved by the Department of Health and Human Services.
Study design Randomised placebo controlled trial
Countries of recruitment United States of America
Disease/condition/study domain Shortness of breath in cancer patients
Participants - inclusion criteria 1. Diagnosis of local or metastatic breast or lung cancer
2. Shortness of breath with onset after cancer diagnosis
3. Life expectancy of at least 4 weeks
Participants - exclusion criteria 1. Prior acupuncture
2. Other conditions suspected of causing shortness of breath, such as congestive heart failure, sarcoid disease, pneumonia, or obesity
3. No chest wall deformity
4. Neuromuscular disorders
5. Pulmonary vascular disease
6. Anaemia
7. Uncontrolled pain or infection
8. Heart valve dysfunction
Anticipated start date 01/11/2001
Anticipated end date 30/11/2003
Status of trial Completed
Patient information material
Target number of participants 40
Interventions Acupuncture versus placebo.
Primary outcome measure(s) Subjective sensation of breathlessness.
Secondary outcome measure(s) Change in medication use.
Sources of funding National Center for Complementary and Alternative Medicine (NCCAM) (USA)
Trial website
Publications Results in http://www.ncbi.nlm.nih.gov/pubmed/16109163
Contact name Dr  Marc  Feinstein
  Address 1275 York Avenue
  City/town New York
  Zip/Postcode 10021
  Country United States of America
  Email feinstem@mskcc.org
Sponsor National Center for Complementary and Alternative Medicine (NCCAM) (USA)
  Address National Institutes of Health
  City/town Bethesda
  Zip/Postcode 20892
  Country United States of America
  Email info@nccam.nih.gov
Date applied 20/04/2005
Last edited 10/08/2009
Date ISRCTN assigned 27/04/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.